Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
Regional Anesthesia and Pain Medicine
|
April 24, 2025
Low-dose remifentanil as an adjunct analgesic is not associated with clinically important opioid-induced hyperalgesia: secondary analysis from a randomized controlled trial
Harsha Shanthanna, Maram A T M Khaled, Alvaro Diaz, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
July 8, 2014
Dopamine D3 receptors in the basolateral amygdala and the lateral habenula modulate cue-induced reinstatement of nicotine seeking
Maram A T M Khaled, Abhiram Pushparaj, Patricia Di Ciano, et al.
Pain Physician
|
April 21, 2026
Comments on "Significant, Meaningful, or Dangerous? Rethinking How We Interpret Evidence"
Maram A T M Khaled, Jessica D Spence, Charles S Brudney, et al.
The International Journal of Neuropsychopharmacology
|
December 10, 2009
The selective dopamine D3 receptor antagonist SB 277011-A, but not the partial agonist BP 897, blocks cue-induced reinstatement of nicotine-seeking
Maram A T M Khaled, Keyghobad Farid Araki, Beth Li, et al.
Plos One
|
September 10, 2015
The Impact of Selective Dopamine D2, D3 and D4 Ligands on the Rat Gambling Task
Patricia Di Ciano, Abhiram Pushparaj, Aaron Kim, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
Regional Anesthesia and Pain Medicine
|
April 24, 2025
Low-dose remifentanil as an adjunct analgesic is not associated with clinically important opioid-induced hyperalgesia: secondary analysis from a randomized controlled trial
Harsha Shanthanna, Maram A T M Khaled, Alvaro Diaz, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
July 8, 2014
Dopamine D3 receptors in the basolateral amygdala and the lateral habenula modulate cue-induced reinstatement of nicotine seeking
Maram A T M Khaled, Abhiram Pushparaj, Patricia Di Ciano, et al.
Pain Physician
|
April 21, 2026
Comments on "Significant, Meaningful, or Dangerous? Rethinking How We Interpret Evidence"
Maram A T M Khaled, Jessica D Spence, Charles S Brudney, et al.
The International Journal of Neuropsychopharmacology
|
December 10, 2009
The selective dopamine D3 receptor antagonist SB 277011-A, but not the partial agonist BP 897, blocks cue-induced reinstatement of nicotine-seeking
Maram A T M Khaled, Keyghobad Farid Araki, Beth Li, et al.
Plos One
|
September 10, 2015
The Impact of Selective Dopamine D2, D3 and D4 Ligands on the Rat Gambling Task
Patricia Di Ciano, Abhiram Pushparaj, Aaron Kim, et al.
Page
of 1